Balyasny Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-140,075
| Closed | -$2.01M | – | 2423 |
|
|
2024
Q4 | $2.01M | Buy |
140,075
+95,820
| +217% | +$1.38M | ﹤0.01% | 1099 |
|
|
2024
Q3 | $999K | Sell |
44,255
-36,056
| -45% | -$814K | ﹤0.01% | 1325 |
|
|
2024
Q2 | $1.56M | Buy |
+80,311
| New | +$1.56M | ﹤0.01% | 1120 |
|
|
2024
Q1 | – | Sell |
-21,745
| Closed | -$1.22M | – | 2444 |
|
|
2023
Q4 | $1.22M | Buy |
+21,745
| New | +$1.22M | ﹤0.01% | 1151 |
|
|
2023
Q2 | – | Sell |
-676,861
| Closed | -$37.8M | – | 2322 |
|
|
2023
Q1 | $37.8M | Buy |
+676,861
| New | +$37.8M | 0.09% | 244 |
|
|
2022
Q3 | – | Sell |
-30,146
| Closed | -$1.36M | – | 2758 |
|
|
2022
Q2 | $1.36M | Buy |
+30,146
| New | +$1.36M | ﹤0.01% | 1298 |
|
|
2021
Q2 | – | Sell |
-19,751
| Closed | -$3.58M | – | 2070 |
|
|
2021
Q1 | $3.58M | Sell |
19,751
-39,312
| -67% | -$7.12M | 0.02% | 684 |
|
|
2020
Q4 | $8.36M | Buy |
+59,063
| New | +$8.36M | 0.05% | 435 |
|
|
2020
Q3 | – | Sell |
-12,848
| Closed | -$1.15M | – | 1371 |
|
|
2020
Q2 | $1.15M | Buy |
+12,848
| New | +$1.15M | 0.01% | 645 |
|